{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T02:26:29Z","timestamp":1795227989806,"version":"4.10.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T00:00:00Z","timestamp":1451520000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.6061\/clinics\/2015(12)03","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T17:23:30Z","timestamp":1450718610000},"page":"775-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Chemotherapy and prognosis in advanced thymic carcinoma patients"],"prefix":"10.1016","volume":"70","author":[{"given":"Zhengbo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.6061\/clinics\/2015(12)03_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.6061\/clinics\/2015(12)03_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"10.6061\/clinics\/2015(12)03_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the european society of thoracic surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.6061\/clinics\/2015(12)03_bib4","article-title":"Chemotherapy for thymic carcinoma and advanced thymoma in adults","volume":"8","author":"Wei","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.6061\/clinics\/2015(12)03_bib5","series-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart","first-page":"152","article-title":"World Health Organization classification of tumours","author":"Marx","year":"2004"},{"issue":"11","key":"10.6061\/clinics\/2015(12)03_bib6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"issue":"4","key":"10.6061\/clinics\/2015(12)03_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"issue":"10 Suppl 4","key":"10.6061\/clinics\/2015(12)03_bib8","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/JTO.0b013e3181f21129","article-title":"The role of chemotherapy in advanced thymoma","volume":"5","author":"Schmitt","year":"2010","journal-title":"J Thorac Oncol. J Thorac Oncol"},{"issue":"8","key":"10.6061\/clinics\/2015(12)03_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","article-title":"Chemotherapy of invasive thymoma","volume":"8","author":"Fornasiero","year":"1990","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.6061\/clinics\/2015(12)03_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.6061\/clinics\/2015(12)03_bib11","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.6061\/clinics\/2015(12)03_bib12","first-page":"194","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","volume":"67","author":"Lemma","year":"2010","journal-title":"Lung Cancer"},{"issue":"6C","key":"10.6061\/clinics\/2015(12)03_bib13","first-page":"4851","article-title":"Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma\u2014three cases","volume":"26","author":"Komatsu","year":"2006","journal-title":"Anticancer Res"},{"issue":"4","key":"10.6061\/clinics\/2015(12)03_bib14","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1177\/030089161309900428","article-title":"Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature","volume":"99","author":"Watanabe","year":"2013","journal-title":"Tumori"},{"issue":"12","key":"10.6061\/clinics\/2015(12)03_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/JTO.0000000000000362","article-title":"Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803","volume":"9","author":"Inoue","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.6061\/clinics\/2015(12)03_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2009.11.057","article-title":"Masaoka Stage and Histologic Grade Predict Prognosis in Patients With Thymic Carcinoma","volume":"89","author":"Hosaka","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.6061\/clinics\/2015(12)03_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2012.12.012","article-title":"Clinical outcomes with chemotherapy for advanced thymic carcinoma","volume":"80","author":"Okuma","year":"2013","journal-title":"Lung Cancer"},{"issue":"1","key":"10.6061\/clinics\/2015(12)03_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","article-title":"Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data","volume":"23","author":"Hoang","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.6061\/clinics\/2015(12)03_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Str\u00f6bel","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"10.6061\/clinics\/2015(12)03_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"issue":"2","key":"10.6061\/clinics\/2015(12)03_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:01:23Z","timestamp":1761721283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222013059"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322015001200775&lng=en&nrm=iso&tlng=em","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4676312\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1807593222013059"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2015(12)03","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy and prognosis in advanced thymic carcinoma patients","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2015(12)03","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}